Case Study: Schrödinger accelerates drug discovery with Sapio Sciences

Accelerating in silico discovery from plasmid to structure

Schrödinger, a leader in computational chemistry, augmented its drug discovery process by establishing an internal wet lab. The challenge was replacing the acquired CRO’s paper-based system with a digital platform to manage massive datasets, ensure traceability, and demonstrate operational value. They sought a unified solution that combined the documentation of an ELN with the data management power of a LIMS.

Sapio Sciences implemented its integrated platform, combining Sapio ELN and Sapio LIMS, with customized workflows for specialized lab processes. The solution provided Schrödinger with improved efficiency, automated cost tracking for expensive media, and enhanced traceability for audits. The results included unified visibility for the entire lab team, strategic insights for resource allocation, and the creation of a lasting knowledge archive to inform future discoveries.

Schrödinger

Rajesh Kumar

Senior Director of Drug Discovery